Почетна › Срцева слабост › Мисури › St. Louis
Клинички испитувања за Срцева слабост во St. Louis, MO
26 студии за Срцева слабост бараат учесници на локации во и околу St. Louis (во радиус од околу 30 милји). Отворете ја студијата за да видите кој може да учествува и како да го контактирате тимот.
Официјален текст на студијата (англиски)
Барате учесници за студија? Истакнете ја на врвот од оваа страница — $99 за 30 дена →
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Се регрутираФаза 3
- St. Louis Heart and Vascular, P.C., St Louis
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Се регрутираФаза 3
- St. Louis Heart and Vascular, P.C., St Louis
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
Се регрутираФаза 2
- Washington University School of Medicine, St Louis
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
Се регрутираФаза 3
- Research Site, Bridgeton · на 15 милји
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Се регрутираФаза 3
- Washington University Center for Advanced Medicine, St Louis
A Study of LY3971297 in Participants With Heart Failure
Се регрутираФаза 1
- Washington University, St Louis
Alleviant ALLAY-HFrEF Study
Се регрутира
- Washington University - St Louis, St Louis
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Се регрутираФаза 3
- Research Site, St Louis
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
Се регрутира
- WashU Medicine, St Louis
A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)
Се регрутираФаза 2
- Local Institution - 109, St Louis
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
Се регрутираФаза 2/3
- Washington University-Pediatric Cardiology/ St. Louis Children's Hospital ( Site 0006), St Louis
AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
Се регрутираФаза 2
- Washington University Center for Advanced Medicine, St Louis
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Се регрутираНабљудувачка студија
- St Louis, St Louis
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
Се регрутираНабљудувачка студија
- Washington University, St Louis
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
Се регрутираФаза 3
- Tenax Investigational Site, St Louis
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Се регрутираФаза 3
- Washington University, St Louis
- Amicis Centers of Clinical Research, St Louis
Alleviant ALLAY-HF Study
Се регрутира
- Washington University - St Louis, St Louis
Assessment of CCM in HF With Higher Ejection Fraction
Се регрутира
- St. Louis Heart and Vascular, Bridgeton · на 15 милји
Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia
Се регрутираФаза 3
- Washington Univ School Of Medicine, St Louis
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
Се регрутираФаза 3
- Washington University - St. Louis Children's Hospital - Cardiology, St Louis
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
Се регрутираФаза 3
- Washington University - St. Louis Children's Hospital - Cardiology, St Louis
The Inorganic Nitrate and eXercise Performance in Heart Failure (iNIX-HF)
Се регрутираФаза 2
- Washington University School of Medicine, St Louis
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Се регрутира
- St. Louis Heart and Vascular, St Louis
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
Се регрутираФаза 3
- Washington University, St Louis
XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)
Се регрутира
- Washington University - Barnes Jewish Health Hospital, St Louis
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
Се регрутираФаза 1/2
- Washington University in Saint Louis, St Louis
Испитувања за Срцева слабост во други градови
- New York City, NY51 студија
- Boston, MA44 студии
- Dallas, TX42 студии
- Houston, TX36 студии
- Cleveland, OH33 студии
- Chicago, IL31 студија
- Philadelphia, PA31 студија
- San Francisco, CA29 студии
- Durham, NC26 студии
- Atlanta, GA25 студии
- Kansas City, MO25 студии
- Baltimore, MD24 студии
Други студии во St. Louis
- Рак на бели дробови со не-мали клетки73 студии
- Рак на дојка64 студии
- Метастатски карцином54 студии
- Колоректален карцином50 студии
- Рак на простата46 студии
- Рак (сите типови)46 студии
- Рак на бели дробови39 студии
- Карцином на јајниците38 студии
- Карцином на панкреасот33 студии
- Рак на ендометриумот29 студии
- Сквамозноклеточен карцином на глава и врат28 студии
- Дебелина25 студии
Од ClinicalTrials.gov, податоци преземени 5.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.